Taltz 80 MG/ML autoinj (2-PK)ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3N5S
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,273
Award facts
- Contract value 100% obligated
- $33,273.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $33,273.47 to AmerisourceBergen Drug Corp for the supply of TALTZ (ixekizumab) 80 mg/mL auto-injector (2-pack) on November 24, 2025. This firm fixed price, non-set-aside contract is categorized as a delivery order with an ultimate completion date of November 25, 2025. The award leverages AmerisourceBergen's substantial indefinite delivery contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 prime vendor agreement running through December 2026 that authorizes the company to supply comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and has demonstrated extensive capability in fulfilling DLA requirements through competitive procurement channels. The company's contract portfolio with the federal government encompasses a diverse range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This delivery order represents a routine procurement action under the broader global pharmaceutical support framework, enabling the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems to access essential medications through DLA's flexible prime vendor contracting approach.
Quick answers
Who was awarded contract SPE2DR26F3N5S?
SPE2DR26F3N5S was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26F3N5S worth?
The government has obligated $33,273 on SPE2DR26F3N5S.
Is contract SPE2DR26F3N5S an order under another contract?
Yes. SPE2DR26F3N5S is a delivery order under SPE2DR25D3008, an indefinite delivery contract.
Was contract SPE2DR26F3N5S competed?
The extent of competition for SPE2DR26F3N5S was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award